-
Not independent, but more inter-dependent than ever before
expresspharma
August 04, 2021
As India's tryst with destiny and disease continues, our identity as citizens of the same planet connects us all, held ransom by the same virus.
-
Biden Administration to support resilience of US pharma supply chain
europeanpharmaceuticalreview
August 03, 2021
US President announces $60 million in funding to support domestic API production and a consortium to onshore essential medicine manufacturing.
-
Achieving Aatmanirbharta in APIs: Are we on the right track?
expresspharma
August 03, 2021
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats.
-
Archimica’s $1.4 Million Manufacturing Expansion
americanpharmaceuticalreview
July 23, 2021
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
-
RBI bulletin calls for diversification of pharma raw material imports, increasing pharma R&D spends
expresspharma
July 16, 2021
Apart from securing own supply chain, the country can also use the pandemic to elevate the sector's position in the global supply chain by standing as a reliable exporter of pharmaceuticals, it said.
-
Purisys Obtains Two Global ISO Certifications
contractpharma
July 09, 2021
Now certified for ISO 17025 for Testing and Calibration Laboratories and ISO 17034 for Reference Material Producers.
-
WuXi STA to build second US pharma manufacturing site at Middletown
cphi-online
June 30, 2021
Facility is expected to come online in 2024 and will feature testing laboratories, manufacture of active pharmaceutical ingredients and manufacture and packaging of solid dosage pharmaceuticals and sterile products.
-
Lonza Expands API Development, Mfg. Facility in China
contractpharma
June 29, 2021
Lonza is investing CHF 20 million in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
-
Novasep Upgrades API Manufacturing Facility
contractpharma
June 28, 2021
Novasep, a supplier of services and technologies for the life sciences industry, is investing $7.3 million at its Mourenx site in France to modernize the API manufacturing facility.
-
Global API market to value $300 billion by 2030
europeanpharmaceuticalreview
June 25, 2021
Researchers anticipate the growth of the aging population and rising investment in biologic drugs to promote the expansion of the global active pharmaceutical ingredient (API) market.